HUP0001185A2 - 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0001185A2 HUP0001185A2 HU0001185A HUP0001185A HUP0001185A2 HU P0001185 A2 HUP0001185 A2 HU P0001185A2 HU 0001185 A HU0001185 A HU 0001185A HU P0001185 A HUP0001185 A HU P0001185A HU P0001185 A2 HUP0001185 A2 HU P0001185A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- mono
- alkoxy
- halogen atom
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 carboxycarbonylalkyl Chemical group 0.000 abstract 12
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000000508 neurotrophic effect Effects 0.000 abstract 1
- 125000003431 oxalo group Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005504 styryl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
A találmány tárgya (I) általános képletű vegyületek, valamint sóik,szolvátjaik és kvaterner ammóniumsóik, a képletben Y jelentése -CH- vagy -N- képletű csoport, R1 jelentése hidrogénatom, halogénatom, trifluormetil-, alkil- vagyalkoxicsoport, R2 jelentése metil- vagy etilcsoport, R3 és R4 jelentése hidrogénatom vagy alkilcsoport, és X jelentése (a) alkil-, alkoxi-, karboxialkil-, alkoxikarbonilalkil-,karboxialkoxi- vagy alkoxikarbonilcsoport, (b) cikloalkil-, cikloalkoxi-, cikloalkilmetil-, cikloalkilamino- vagyciklohexilcsoport, amelyek adott esetben halogénatommal, hidroxil-,alkoxi-, karboxil-, alkoxikarbonil-, amino- vagy mono- vagy dialkil-aminocsoporttal lehetnek helyettesítve, vagy (c) fenil-, fenoxi-, fenilamino-, N-alkilfenilamino-, fenil-metil-,feniletil-, fenilkarbonil-, feniltio-, fenil-szulfonil-,fenilszulfinil- vagy sztirilcsoport, amelyek adott esetben afenilcsoporton egyszeresen vagy többszörösen helyettesítve lehetnekhalogénatommal, trifluormetilcsoporttal, alkil-, alkoxi-, ciano-,amino-, mono- vagy dialkil-amino-, acilaminokarboxil-,alkoxikarbonil-, amino-karbonil-, mono- vagy dialkil-aminokarbonil-,aminoalkil-, hidroxialkil- vagy halogénalkilcsoporttal. A találmányszerinti vegyületek neurotrofikus és neuroprotektív aktivitássalrendelkeznek. A találmány tárgykörébe tartoznak az (I) általánosképletű vegyületeket tartalmazó gyógyszerkészítmények is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615335A FR2757160B1 (fr) | 1996-12-13 | 1996-12-13 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
| PCT/FR1997/002286 WO1998025903A1 (fr) | 1996-12-13 | 1997-12-12 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0001185A2 true HUP0001185A2 (hu) | 2000-10-28 |
| HUP0001185A3 HUP0001185A3 (en) | 2002-10-28 |
| HU224347B1 HU224347B1 (hu) | 2005-08-29 |
Family
ID=9498641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001185A HU224347B1 (hu) | 1996-12-13 | 1997-12-12 | 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6034090A (hu) |
| EP (1) | EP0950048B1 (hu) |
| JP (1) | JP3881384B2 (hu) |
| KR (1) | KR100560358B1 (hu) |
| CN (1) | CN1129579C (hu) |
| AT (1) | ATE202561T1 (hu) |
| AU (1) | AU730143B2 (hu) |
| BR (1) | BR9713916A (hu) |
| CA (1) | CA2275353C (hu) |
| CY (1) | CY2274B1 (hu) |
| CZ (1) | CZ289789B6 (hu) |
| DE (1) | DE69705429T2 (hu) |
| DK (1) | DK0950048T3 (hu) |
| EE (1) | EE03763B1 (hu) |
| ES (1) | ES2160977T3 (hu) |
| FR (1) | FR2757160B1 (hu) |
| GR (1) | GR3036643T3 (hu) |
| HK (1) | HK1023997A1 (hu) |
| HU (1) | HU224347B1 (hu) |
| IL (1) | IL130003A (hu) |
| IS (1) | IS1969B (hu) |
| NO (1) | NO312720B1 (hu) |
| NZ (1) | NZ336033A (hu) |
| PL (1) | PL190789B1 (hu) |
| PT (1) | PT950048E (hu) |
| RS (1) | RS49807B (hu) |
| RU (1) | RU2189975C2 (hu) |
| SI (1) | SI0950048T1 (hu) |
| SK (1) | SK283331B6 (hu) |
| TR (1) | TR199901291T2 (hu) |
| UA (1) | UA52707C2 (hu) |
| WO (1) | WO1998025903A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| FR2832405B1 (fr) * | 2001-11-19 | 2004-12-10 | Sanofi Synthelabo | Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1321701A (en) * | 1969-10-01 | 1973-06-27 | Continental Pharma | Amino-alcohols their salts and process for prepairing the same |
| IE34545B1 (en) * | 1969-10-01 | 1975-06-11 | Continental Pharma | Amino-alcohols,their salts and process for preparing the same |
| FR2650505B1 (fr) * | 1989-08-07 | 1994-06-03 | Midy Spa | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale |
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
-
1996
- 1996-12-13 FR FR9615335A patent/FR2757160B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-12 IL IL13000397A patent/IL130003A/en not_active IP Right Cessation
- 1997-12-12 BR BR9713916-5A patent/BR9713916A/pt not_active Application Discontinuation
- 1997-12-12 ES ES97951323T patent/ES2160977T3/es not_active Expired - Lifetime
- 1997-12-12 EP EP97951323A patent/EP0950048B1/fr not_active Expired - Lifetime
- 1997-12-12 NZ NZ336033A patent/NZ336033A/xx unknown
- 1997-12-12 SK SK786-99A patent/SK283331B6/sk unknown
- 1997-12-12 TR TR1999/01291T patent/TR199901291T2/xx unknown
- 1997-12-12 JP JP52632098A patent/JP3881384B2/ja not_active Expired - Fee Related
- 1997-12-12 UA UA99063286A patent/UA52707C2/uk unknown
- 1997-12-12 KR KR1019997005203A patent/KR100560358B1/ko not_active IP Right Cessation
- 1997-12-12 SI SI9730187T patent/SI0950048T1/xx unknown
- 1997-12-12 US US09/331,006 patent/US6034090A/en not_active Expired - Fee Related
- 1997-12-12 RU RU99115083/04A patent/RU2189975C2/ru not_active IP Right Cessation
- 1997-12-12 CZ CZ19992113A patent/CZ289789B6/cs not_active IP Right Cessation
- 1997-12-12 AU AU54893/98A patent/AU730143B2/en not_active Ceased
- 1997-12-12 CN CN97180581A patent/CN1129579C/zh not_active Expired - Fee Related
- 1997-12-12 DK DK97951323T patent/DK0950048T3/da active
- 1997-12-12 PL PL334071A patent/PL190789B1/pl unknown
- 1997-12-12 AT AT97951323T patent/ATE202561T1/de not_active IP Right Cessation
- 1997-12-12 PT PT97951323T patent/PT950048E/pt unknown
- 1997-12-12 CA CA002275353A patent/CA2275353C/en not_active Expired - Fee Related
- 1997-12-12 EE EEP199900237A patent/EE03763B1/xx not_active IP Right Cessation
- 1997-12-12 HU HU0001185A patent/HU224347B1/hu not_active IP Right Cessation
- 1997-12-12 DE DE69705429T patent/DE69705429T2/de not_active Expired - Fee Related
- 1997-12-12 RS YUP-243/99A patent/RS49807B/sr unknown
- 1997-12-12 WO PCT/FR1997/002286 patent/WO1998025903A1/fr not_active Application Discontinuation
-
1999
- 1999-06-10 IS IS5075A patent/IS1969B/is unknown
- 1999-06-11 NO NO19992869A patent/NO312720B1/no unknown
-
2000
- 2000-05-30 HK HK00103181A patent/HK1023997A1/xx not_active IP Right Cessation
-
2001
- 2001-09-18 GR GR20010401501T patent/GR3036643T3/el not_active IP Right Cessation
-
2002
- 2002-05-15 CY CY0200027A patent/CY2274B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP12708A (en) | Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| TR200200415T2 (tr) | İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler. | |
| DE69523169T2 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
| HUP0300263A2 (hu) | Antranil-amid-származékok, alkalmazásuk és a vegyületeket hatóanyagként tartalmazó artropodicid készítmények | |
| HUP0103366A2 (hu) | Citokin inhibítorként használható amidszármazékok | |
| HUP0105039A2 (hu) | Fungicid hatású propargil-éter-származékok, előállításuk és alkalmazásuk | |
| YU49486B (sh) | Postupci i intermedijeri za dobijanje 1-benzil-4-((5,6-dimetoksi-1-indanon)-2-il) metilpiperidina | |
| HUP0101132A2 (hu) | Amidvegyületet tartalmazó, szinergetikus hatású fungicid hatóanyag keverék és alkalmazása | |
| NO971555D0 (no) | N-(orto-substituerte benzyloksy)iminderivater og deres anvendelse som fungicider, akaricider eller insekticider | |
| HUP0301587A2 (hu) | Foszfodiészteráz V gátló hatású 5-amino-alkil-pirazolo[4,3-d]pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárások az elżállításaikra | |
| TW324007B (en) | N-substituted diazabicycloheptane derivative and its pharmaceutical use | |
| HUP0001185A2 (hu) | 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE169921T1 (de) | Optisch aktive beta-aminoalkoxyborankomplexe | |
| DK0891341T3 (da) | 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider | |
| NO975402L (no) | Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem | |
| HUP0002791A2 (hu) | Szinergetikus fungicid hatóanyag-keverék és alkalmazása | |
| NO992870L (no) | Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem | |
| NO981000L (no) | 4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelse | |
| HUP0104641A2 (hu) | IL-5 citokint inhibitáló 6-azauracil-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HFG4 | Patent granted, date of granting |
Effective date: 20050620 |
|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |